Search research articles
Contact Us
Filters
Showing results (511-520 of 544) with videos related to
Page
of 55
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 2, 2011
Implementing a geriatric assessment in cooperative group clinical cancer trials: CALGB 360401
Arti Hurria, Constance T Cirrincione, Hyman B Muss, et al.
Nature Cell Biology
|
November 8, 2016
Lgr6 labels a rare population of mammary gland progenitor cells that are able to originate luminal mammary tumours
Leander Blaas, Fabio Pucci, Hendrik A Messal, et al.
Molecular Therapy. Oncology
|
April 15, 2025
Erratum: Dual CARM1-and IKZF3-targeting: A novel approach to multiple myeloma therapy
Wei Ni, Swati Garg, Basudev Chowdhury, et al.
Blood
|
May 5, 2017
Selective inhibition of nuclear export with selinexor in patients with non-Hodgkin lymphoma
John Kuruvilla, Michael Savona, Rachid Baz, et al.
Blood
|
March 25, 2017
A phase 1 clinical trial of single-agent selinexor in acute myeloid leukemia
Ramiro Garzon, Michael Savona, Rachid Baz, et al.
Journal of Veterinary Internal Medicine
|
October 5, 2020
Lyophilized platelets versus cryopreserved platelets for management of bleeding in thrombocytopenic dogs: A multicenter randomized clinical trial
Robert Goggs, Benjamin M Brainard, Dana N LeVine, et al.
Blood Advances
|
September 28, 2021
PD-1 inhibition in advanced myeloproliferative neoplasms
Gabriela Hobbs, Cansu Cimen Bozkus, Erin Moshier, et al.
Leukemia
|
July 30, 2021
Small molecule inhibition of deubiquitinating enzyme JOSD1 as a novel targeted therapy for leukemias with mutant JAK2
Jing Yang, Ellen L Weisberg, Xiaoxi Liu, et al.
Blood
|
September 30, 2008
Antileukemic effects of the novel, mutant FLT3 inhibitor NVP-AST487: effects on PKC412-sensitive and -resistant FLT3-expressing cells
Ellen Weisberg, Johannes Roesel, Guido Bold, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 29, 2013
A genome-wide aberrant RNA splicing in patients with acute myeloid leukemia identifies novel potential disease markers and therapeutic targets
Sophia Adamia, Benjamin Haibe-Kains, Patrick M Pilarski, et al.
Page
of 55
Search research articles
Search
Showing results (511-520 of 544) with videos related to
Sort By:
Page
of 55
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 2, 2011
Implementing a geriatric assessment in cooperative group clinical cancer trials: CALGB 360401
Arti Hurria, Constance T Cirrincione, Hyman B Muss, et al.
Nature Cell Biology
|
November 8, 2016
Lgr6 labels a rare population of mammary gland progenitor cells that are able to originate luminal mammary tumours
Leander Blaas, Fabio Pucci, Hendrik A Messal, et al.
Molecular Therapy. Oncology
|
April 15, 2025
Erratum: Dual CARM1-and IKZF3-targeting: A novel approach to multiple myeloma therapy
Wei Ni, Swati Garg, Basudev Chowdhury, et al.
Blood
|
May 5, 2017
Selective inhibition of nuclear export with selinexor in patients with non-Hodgkin lymphoma
John Kuruvilla, Michael Savona, Rachid Baz, et al.
Blood
|
March 25, 2017
A phase 1 clinical trial of single-agent selinexor in acute myeloid leukemia
Ramiro Garzon, Michael Savona, Rachid Baz, et al.
Journal of Veterinary Internal Medicine
|
October 5, 2020
Lyophilized platelets versus cryopreserved platelets for management of bleeding in thrombocytopenic dogs: A multicenter randomized clinical trial
Robert Goggs, Benjamin M Brainard, Dana N LeVine, et al.
Blood Advances
|
September 28, 2021
PD-1 inhibition in advanced myeloproliferative neoplasms
Gabriela Hobbs, Cansu Cimen Bozkus, Erin Moshier, et al.
Leukemia
|
July 30, 2021
Small molecule inhibition of deubiquitinating enzyme JOSD1 as a novel targeted therapy for leukemias with mutant JAK2
Jing Yang, Ellen L Weisberg, Xiaoxi Liu, et al.
Blood
|
September 30, 2008
Antileukemic effects of the novel, mutant FLT3 inhibitor NVP-AST487: effects on PKC412-sensitive and -resistant FLT3-expressing cells
Ellen Weisberg, Johannes Roesel, Guido Bold, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 29, 2013
A genome-wide aberrant RNA splicing in patients with acute myeloid leukemia identifies novel potential disease markers and therapeutic targets
Sophia Adamia, Benjamin Haibe-Kains, Patrick M Pilarski, et al.
Page
of 55